Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
暂无分享,去创建一个
Thomas Hambrock | Tom W J Scheenen | Thiele Kobus | Henkjan J Huisman | Geert J S Litjens | H. Huisman | T. Scheenen | G. Litjens | J. Barentsz | T. Hambrock | T. Kobus | E. Vos | Jelle O Barentsz | Christina A Hulsbergen-van de Kaa | Eline K Vos | C. Hulsbergen–van de Kaa
[1] J Alfred Witjes,et al. Microvascularity in transition zone prostate tumors resembles normal prostatic tissue , 2013, The Prostate.
[2] Thomas Hambrock,et al. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. , 2011, European urology.
[3] A. Evans,et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. , 2010, Radiology.
[4] S. Mancino,et al. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience , 2008, La radiologia medica.
[5] Karin Haustermans,et al. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology. , 2012, European journal of radiology.
[6] L. Turnbull,et al. Description of magnetic resonance imaging‐derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions , 2009, BJU international.
[7] S. Shariat,et al. Magnetic resonance imaging-targeted prostate biopsy: back to the future. , 2013, European urology.
[8] C. Lawton,et al. Screening and Prostate-Cancer Mortality in a Randomized European Study , 2010 .
[9] H. Huisman,et al. Accurate estimation of pharmacokinetic contrast‐enhanced dynamic MRI parameters of the prostate , 2001, Journal of magnetic resonance imaging : JMRI.
[10] H. Schlemmer,et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004, European Radiology.
[11] Thomas Hambrock,et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.
[12] S. Fosså,et al. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study , 2009, BJU international.
[13] P. P. Iu,et al. ESUR prostate MR guidelines. , 2013, European radiology.
[14] T. Scheenen,et al. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. , 2012, Radiology.
[15] Bernd Hamm,et al. Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer , 2011, European Radiology.
[16] D P Dearnaley,et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.
[17] Tristan Barrett,et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. , 2007, AJR. American journal of roentgenology.
[18] Mehdi Moradi,et al. Multiparametric MRI maps for detection and grading of dominant prostate tumors , 2012, Journal of magnetic resonance imaging : JMRI.
[19] Thomas Hambrock,et al. Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI. , 2008, Medical physics.
[20] H. Ozen,et al. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. , 2007, Urologic oncology.
[21] Thorsten Schlomm,et al. Prognostic value of microvessel density in prostate cancer: a tissue microarray study , 2010, World Journal of Urology.
[22] A. Jemal,et al. Global Cancer Statistics , 2011 .
[23] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[24] Yousef Mazaheri,et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.
[25] A. Oto,et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. , 2011, AJR. American journal of roentgenology.
[26] G S Karczmar,et al. A new method for imaging perfusion and contrast extraction fraction: Input functions derived from reference tissues , 1998, Journal of magnetic resonance imaging : JMRI.
[27] Thomas Hambrock,et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.
[28] W. I. Tseng,et al. Washout gradient in dynamic contrast‐enhanced MRI is associated with tumor aggressiveness of prostate cancer , 2012, Journal of magnetic resonance imaging : JMRI.
[29] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[30] P. Choyke,et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.
[31] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[32] A. Neugut,et al. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. , 1999, Urology.